Advertisement

Product › Details
Anc-AAV technology
![]() |
Next higher product group | adenoviral vector |
![]() |
Status | 2016-09-12 existent |
Record changed: 2017-04-01 |
Advertisement

More documents for adenoviral vector
- [1] Novartis AG. (11/21/24). "Press Release: Addressing Unmet Needs for Inherited Neuromuscular Diseases. Novartis Has Acquired Kate Therapeutics to Further Enhance and Strengthen Our Ongoing Efforts to Advance Gene Therapies for Patients"....
- [2] Capsida Biotherapeutics Inc.. (10/3/23). "Press Release: Capsida Biotherapeutics Enters Strategic Collaboration with Kate Therapeutics to Manufacture KateTx’s Next-Generation Gene Therapies". Thousand Oaks, CA & San Diego, CA....
- [3] Rentschler Biopharma SE. (8/23/23). "Press Release: Collaboration to Improve Process Analytical Technologies and AAV Manufacturing for Gene Therapies". Stevenage, London & Laupheim....
- [4] Ascend Gene and Cell Therapies Ltd.. (5/9/23). "Press Release: Gene and Cell Therapy Manufacturing Specialist Ascend Launches with over $130M of Funding as Expert Teams Merge". London....
- [5] Bayer AG. (3/9/23). "Press Release: AskBio Announces Gustavo Pesquin as New CEO". Research Triangle Park, NC....
- [6] Freeline Therapeutics Holdings plc. (2/10/23). "Press Release: Freeline Announces Closing of Sale of Its CMC-focused German Subsidiary". London....
- [7] Apertura Gene Therapy LLC. (7/14/22). "Press Release: Apertura Appoints Gene Therapy Executive Joseph La Barge as Chief Executive Officer". New York, NY & Cambridge, MA....
- [8] ViGeneron GmbH. (4/6/22). "Press Release: ViGeneron Signs Gene Therapy Strategic Collaboration and Option Agreement with Regeneron for One Inherited Retinal Disease Target". Munich....
- [9] CRISPR Therapeutics AG. (6/15/21). "Press Release: CRISPR Therapeutics and Capsida Biotherapeutics Announce Strategic Collaboration to Develop Gene-Edited Therapies for Amyotrophic Lateral Sclerosis and Friedreich’s Ataxia". Zug, Cambridge, MA & Thousan...
- [10] Forbion Capital Partners. (2/10/21). "Press Release: Launch of Novel Gene Therapy Company, VectorY, to Develop Innovative Vectorized Antibodies". Amsterdam....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top